SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-074705
Filing Date
2022-11-23
Accepted
2022-11-23 06:09:57
Documents
38
Period of Report
2022-11-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea169173-8k_clarus.htm   iXBRL 8-K 34068
2 CLARUS THERAPEUTICS HOLDINGS, INC., MONTHLY OPERATING REPORT, DATED NOVEMBER 21, ea169173ex99-1_clarus.htm EX-99.1 8927
3 CLARUS THERAPEUTICS, INC., MONTHLY OPERATING REPORT, DATED NOVEMBER 21, 2022 ea169173ex99-2_clarus.htm EX-99.2 8923
4 GRAPHIC ex99-1_001.jpg GRAPHIC 226192
5 GRAPHIC ex99-1_002.jpg GRAPHIC 293530
6 GRAPHIC ex99-1_003.jpg GRAPHIC 238613
7 GRAPHIC ex99-1_004.jpg GRAPHIC 221426
8 GRAPHIC ex99-1_005.jpg GRAPHIC 231592
9 GRAPHIC ex99-1_006.jpg GRAPHIC 226509
10 GRAPHIC ex99-1_007.jpg GRAPHIC 228694
11 GRAPHIC ex99-1_008.jpg GRAPHIC 260613
12 GRAPHIC ex99-1_009.jpg GRAPHIC 332903
13 GRAPHIC ex99-1_010.jpg GRAPHIC 586566
14 GRAPHIC ex99-1_011.jpg GRAPHIC 554763
15 GRAPHIC ex99-1_012.jpg GRAPHIC 337566
16 GRAPHIC ex99-2_001.jpg GRAPHIC 254134
17 GRAPHIC ex99-2_002.jpg GRAPHIC 347467
18 GRAPHIC ex99-2_003.jpg GRAPHIC 254269
19 GRAPHIC ex99-2_004.jpg GRAPHIC 222350
20 GRAPHIC ex99-2_005.jpg GRAPHIC 256507
21 GRAPHIC ex99-2_006.jpg GRAPHIC 226554
22 GRAPHIC ex99-2_007.jpg GRAPHIC 229340
23 GRAPHIC ex99-2_008.jpg GRAPHIC 296951
24 GRAPHIC ex99-2_009.jpg GRAPHIC 375596
25 GRAPHIC ex99-2_010.jpg GRAPHIC 669531
26 GRAPHIC ex99-2_011.jpg GRAPHIC 645761
27 GRAPHIC ex99-2_012.jpg GRAPHIC 377822
  Complete submission text file 0001213900-22-074705.txt   11097891

Data Files

Seq Description Document Type Size
28 XBRL SCHEMA FILE crxtq-20221121.xsd EX-101.SCH 3260
29 XBRL LABEL FILE crxtq-20221121_lab.xml EX-101.LAB 34240
30 XBRL PRESENTATION FILE crxtq-20221121_pre.xml EX-101.PRE 22380
32 EXTRACTED XBRL INSTANCE DOCUMENT ea169173-8k_clarus_htm.xml XML 3408
Mailing Address 355 S. GRAND AVENUE, SUITE 1450 LOS ANGELES CA 90071
Business Address 355 S. GRAND AVENUE, SUITE 1450 LOS ANGELES CA 90071 (847) 562-4300
Clarus Therapeutics Holdings, Inc. (Filer) CIK: 0001817944 (see all company filings)

IRS No.: 851231852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39802 | Film No.: 221412200
SIC: 2836 Biological Products, (No Diagnostic Substances)